Chiasma Inc
CHMA·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$2.84
Today
+0.0%
YTD
+0.0%
About
With international operations, Chiasma is a healthcare firm that develops oral medications used for the treatment of both serious and rare chronic diseases. Founded in 2001, the firm's headquarters are based in Needham, Massachusetts. Its stock is listed on the NASDAQ GS under the CHMA ticker. Increase your eToro portfolio's diversity by investing in CHMA stock now.
Price chart
Closing price history for CHMA (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.35
P/S (TTM)Unknown
P/B (TTM)3.47
Market cap$237.81M
Cap tierMicro-cap
Industry avg P/E-43.27
Profitability
Gross margin62.24%
EBIT margin-2408.65%
Net margin-1587.73%
ROE-133.81%
ROA-73.05%
Earnings & Revenue
Revenue (TTM)$3.03M
Revenue growth (1Y)Unknown
EPS (TTM)-$1.60
Free cash flow$-83.47M
Total debt$961,000.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.87
Employees85
Next earnings9 Aug '21
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.